Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 1 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 05, 2022 Filed May 6, 2022 13:58 UTC |
BURGESS ERNEST G IIIDirector
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011296 · rdgdoc.xml · derivative · entry 7 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:28 UTC |
HASSAN EMIL EDirector
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011327 · rdgdoc.xml · derivative · entry 7 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F2 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:28 UTC |
HASSAN EMIL EDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-22-011327 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2022-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:28 UTC |
HASSAN EMIL EDirector
|
Exercise / conversionShares of Common Stock | 7,500 | $72.94 | $547,050.00 |
DisclosureSEC source: 0001437749-22-011327 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 78,595 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 17:59 UTC |
ABERNATHY JAMES PAULDirector
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011297 · rdgdoc.xml · derivative · entry 7 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 17:57 UTC |
Trail Sandra Y.Director
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011295 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:13 UTC |
McIntosh Leroy E. Jr.SVP, Anc Srvcs & Srvc Strategy
|
GrantShares of Common Stock | 1,595 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004921 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,601.779 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 22:04 UTC |
Flatt Stephen FowlerDirector · CEO
|
GrantCommon Stock | 4,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004912 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,318 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 21:26 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
GrantShares of Common Stock held in my name | 1,940 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004872 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,701 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:51 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
GrantShares of Common Stock | 2,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004834 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,758.6456 F1 · shares: [FN on Amnt] Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:45 UTC |
SMITH JEFFREY RUSSELLSVP & Treasurer
|
GrantShares of Common Stock held in my name | 2,122 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004829 · rdgdoc.xml · nonDerivative · entry 1 SMITH JEFFREY RUSSELL · CIK 0001694452 · SVP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,961 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:42 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
GrantShares of Common Stock held in my name | 1,282 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004826 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,109.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:41 UTC |
Ussery Robert MichaelPresident & COO
|
GrantShares of Common Stock owned by myself & spouse | 4,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004823 · rdgdoc.xml · nonDerivative · entry 1 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 151,020 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 25, 2022 Filed Mar 1, 2022 20:39 UTC |
McCreary Josh ASenior VP & General Counsel
|
GrantShares of Common Stock | 1,908 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-004821 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,854 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2023, the next 33 1/3% vesting on 1/1/2024, and the final 33 1/3% vesting on 1/1/2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 22:49 UTC |
SMITH JEFFREY RUSSELLSVP & Treasurer
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004218 · rdgdoc.xml · derivative · entry 3 SMITH JEFFREY RUSSELL · CIK 0001694452 · SVP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:59 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004204 · rdgdoc.xml · derivative · entry 2 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 22:29 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004214 · rdgdoc.xml · derivative · entry 3 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:53 UTC |
McCreary Josh ASenior VP & General Counsel
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004199 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:55 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004201 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:37 UTC |
Flatt Stephen FowlerDirector · CEO
|
GrantOption to Purchase Common Stock · Derivative | 14,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004195 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,200 Underlying: Common Stock · 14,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:28 UTC |
Ussery Robert MichaelPresident & COO
|
GrantOption to Purchase Common Stock · Derivative | 12,700 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004193 · rdgdoc.xml · derivative · entry 3 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,700 Underlying: Common Stock · 12,700 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 21:25 UTC |
McIntosh Leroy E. Jr.SVP, Anc Srvcs & Srvc Strategy
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $63.96 | $0.00 |
DisclosureSEC source: 0001437749-22-004192 · rdgdoc.xml · derivative · entry 2 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2027-02-18 F1 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on February 18, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 18, 2023; one-third (1/3) will vest on February 18, 2024; and the final one-third (1/3) will vest on February 18, 2025. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 22:37 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Tax withholdingShares of Common Stock | 247 | $67.94 | $16,781.18 |
DisclosureSEC source: 0001437749-22-000203 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,227.2702 F1 · shares: On 1/1/2022, 33 1/3 (or 834 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 247 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 22:36 UTC |
SMITH JEFFREY RUSSELLSVP & Treasurer
|
Tax withholdingShares of Common Stock held in my name | 247 | $67.94 | $16,781.18 |
DisclosureSEC source: 0001437749-22-000202 · rdgdoc.xml · nonDerivative · entry 1 SMITH JEFFREY RUSSELL · CIK 0001694452 · SVP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,839 F1 · shares: On 1/1/2022, 33 1/3 (or 835 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 247 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 22:35 UTC |
McCreary Josh ASenior VP & General Counsel
|
Tax withholdingShares of Common Stock | 108 | $67.94 | $7,337.52 |
DisclosureSEC source: 0001437749-22-000200 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 946 F1 · shares: On 1/1/2022, 33 1/3 (or 367 shares) of restricted stock originally granted on 2/21/2020 and 2/24/2021 vested. The Company withheld 108 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 3, 2022 22:33 UTC |
McIntosh Leroy E. Jr.SVP, Anc Srvcs & Srvc Strategy
|
Tax withholdingShares of Common Stock held in my name or my spouse's name | 173 | $67.94 | $11,753.62 |
DisclosureSEC source: 0001437749-22-000199 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,003 F1 · shares: On 1/1/2022, 33 1/3 (or 584 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 173 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 22:37 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
Tax withholdingShares of Common Stock held in my name | 202 | $67.94 | $13,723.88 |
DisclosureSEC source: 0001437749-22-000321 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,723 F1 · shares: On 1/1/2022, 33 1/3 (or 684 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 202 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 22:38 UTC |
Flatt Stephen FowlerDirector · CEO
|
Tax withholdingCommon Stock | 577 | $67.94 | $39,201.38 |
DisclosureSEC source: 0001437749-22-000323 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,518 F1 · shares: On 1/1/2022, 33 1/3 (or 1,948 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 577 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 22:34 UTC |
Ussery Robert MichaelPresident & COO
|
Tax withholdingShares of Common Stock owned by myself & spouse | 544 | $67.94 | $36,959.36 |
DisclosureSEC source: 0001437749-22-000317 · rdgdoc.xml · nonDerivative · entry 1 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 146,518 F1 · shares: On 1/1/2022, 33 1/3 (or 1,838 shares) of restricted stock originally granted on 2/22/2019, 2/21/2020, and 2/24/2021 vested. The Company withheld 544 shares to pay tax obligations. Read SEC document |
| January 01, 2022 Filed Jan 4, 2022 22:33 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Tax withholdingShares of Common Stock held in my name | 67 | $67.94 | $4,551.98 |
DisclosureSEC source: 0001437749-22-000313 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,732.8743 F1 · shares: On 1/1/2022, 33 1/3 (or 229 shares) of restricted stock originally granted on 2/21/2020 and 2/24/2021 vested. The Company withheld 67 shares to pay tax obligations. Read SEC document |
| December 30, 2021 Filed Jan 12, 2022 22:02 UTC |
LAROCHE RICHARD F JRDirector
|
GiftCommon Stock - Held in my name or my wife's name | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-22-000814 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 189,313 Read SEC document |
| December 29, 2021 Filed Dec 29, 2021 20:05 UTC |
LAROCHE RICHARD F JRDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 5,000 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-21-029394 · rdgdoc.xml · derivative · entry 6 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 29, 2021 Filed Dec 29, 2021 20:05 UTC |
LAROCHE RICHARD F JRDirector
|
Exercise / conversionCommon Stock - Held in my name or my wife's name | 5,000 | $61.90 | $309,500.00 |
DisclosureSEC source: 0001437749-21-029394 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:53 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 34,630 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-21-025971 · rdgdoc.xml · derivative · entry 4 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,370 Underlying: Common Stock · 36,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the option to grant the ability to exercise up to 100% of this option, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the option to grant the ability to exercise up to 100% of this option, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:53 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
Tax withholdingShares of Common Stock held in my name | 33,445 | $76.35 | $2,553,525.75 |
DisclosureSEC source: 0001437749-21-025971 · rdgdoc.xml · nonDerivative · entry 3 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,925 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:53 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
Exercise / conversionShares of Common Stock held in my name | 34,630 | $72.94 | $2,525,912.20 |
DisclosureSEC source: 0001437749-21-025971 · rdgdoc.xml · nonDerivative · entry 2 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,370 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the option to grant the ability to exercise up to 100% of this option, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:59 UTC |
Flatt Stephen FowlerDirector · CEO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 40,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-21-025974 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 45,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:59 UTC |
Flatt Stephen FowlerDirector · CEO
|
Tax withholdingShares of Common Stock held in my name | 38,633 | $76.35 | $2,949,629.55 |
DisclosureSEC source: 0001437749-21-025974 · rdgdoc.xml · nonDerivative · entry 2 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,095 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 05, 2021 Filed Nov 9, 2021 22:59 UTC |
Flatt Stephen FowlerDirector · CEO
|
Exercise / conversionShares of Common Stock held in my name | 40,000 | $72.94 | $2,917,600.00 |
DisclosureSEC source: 0001437749-21-025974 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,728 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 21:21 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 6,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-21-027842 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 21:21 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Tax withholdingShares of Common Stock held in my name | 5,811 | $76.35 | $443,669.85 |
DisclosureSEC source: 0001437749-21-027842 · rdgdoc.xml · nonDerivative · entry 2 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799.8743 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 05, 2021 Filed Dec 3, 2021 21:21 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Exercise / conversionShares of Common Stock held in my name | 6,000 | $72.94 | $437,640.00 |
DisclosureSEC source: 0001437749-21-027842 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,610.8743 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the Company's 2010 Omnibus Equity Incentive plan on March 14, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 04, 2021 Filed Nov 9, 2021 23:11 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 24,000 | $0.00 Strike: $72.94 | $0.00 |
DisclosureSEC source: 0001437749-21-025977 · rdgdoc.xml · derivative · entry 3 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 24,000 shares Expires 2022-03-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F1 · derivative.exercise_date: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| November 04, 2021 Filed Nov 9, 2021 23:11 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Tax withholdingShares of Common Stock held in my name | 23,174 | $76.35 | $1,769,334.90 |
DisclosureSEC source: 0001437749-21-025977 · rdgdoc.xml · nonDerivative · entry 2 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,474.2702 F2 · shares: Shares were withheld by the Company to pay the exercise price and withholding tax obligations. F3 · balance_after: Total amount of shares beneficially owned following transactions reported on this form. Read SEC document |
| November 04, 2021 Filed Nov 9, 2021 23:11 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Exercise / conversionShares of Common Stock held in my name | 24,000 | $72.94 | $1,750,560.00 |
DisclosureSEC source: 0001437749-21-025977 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,648.2702 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| August 31, 2021 Filed Nov 9, 2021 22:53 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
GiftShares of Common Stock held in my name | 400 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-21-025971 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,740 Read SEC document |
| May 27, 2021 Filed May 28, 2021 16:38 UTC |
ADAMS W ANDREWDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001437749-21-013741 · rdgdoc.xml · derivative · entry 5 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 27, 2021 Filed May 28, 2021 16:38 UTC |
ADAMS W ANDREWDirector
|
Exercise / conversionShares of Common Stock - my name or my spouse's name | 7,500 | $62.78 | $470,850.00 |
DisclosureSEC source: 0001437749-21-013741 · rdgdoc.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,970 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on June 2, 2016. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 19, 2021 Filed May 21, 2021 12:30 UTC |
HASSAN EMIL EDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $62.78 | $0.00 |
DisclosureSEC source: 0001437749-21-012988 · rdgdoc.xml · derivative · entry 2 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,500 shares Expires 2021-06-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 19, 2021 Filed May 21, 2021 12:30 UTC |
HASSAN EMIL EDirector
|
Exercise / conversionShares of Common Stock | 7,500 | $62.78 | $470,850.00 |
DisclosureSEC source: 0001437749-21-012988 · rdgdoc.xml · nonDerivative · entry 1 HASSAN EMIL E · CIK 0001288063 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,095 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.